Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

04/11/2021 04:30

Nov 4 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             37.59               36.79            79.20    
                 (+2.2 pct)          (-18.6 pct)      (+5.6 pct)  
  Operating          9.04                9.78            18.80    
                 (-7.6 pct)          (-28.8 pct)      (+5.7 pct)  
  Recurring          9.29               10.01            19.20    
                 (-7.2 pct)          (-28.1 pct)      (+5.4 pct)  
  Net                6.72                7.23            14.00    
                 (-7.0 pct)          (-24.3 pct)      (+4.4 pct)  
  EPS            176.24 yen          186.15 yen       370.19 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T